glp-1 colorectal cancer death risk study november 2025 Colon patients using GLP-1s had lower rates: glp-1 colorectal cancer death risk

We're here to help you!

Systematic thinking saves lives

Participants in the oral semaglutide arm underwent a dose-escalation schedule (3 mg daily for 4 weeks, followed by 7 mg daily for 4 weeks, then 14 mg daily for the remainder of the trial) to minimize gastrointestinal side effects

Hailey-Hailey Disease HHD, also known as benign familial pemphigus, is a rare autosomal dominant disorder that affects keratinocyte adhesion

This interaction initiates the transcription of a broad array of cytoprotective genes, markedly enhancing the synthesis of intracellular glutathione and upregulating phase II detoxification and antioxidant enzymes, including glutathione S-transferases (GSTs) and heme oxygenase-1 (HO-1)